The Usefulness of Indocyanine Green in Modern Gynecological Oncology-Analysis, Literature Review, and Future

Michał Kostrzanowski1, Grzegorz Ziółkowski1, Agata Mandes1

  • 1Department of Gynecology and Gynecologic Oncology, Center of Postgraduate Medical Education, Cegłowska 80, 01-809 Warsaw, Poland.

Cancers
|September 27, 2025
PubMed

Insights

Indocyanine green (ICG) enhances surgical precision in gynecological oncology by improving visualization and localization. Future research explores its potential as a cytotoxic agent for cancer therapy.

Area of Science:

  • Oncology
  • Surgical Innovation

Background:

  • Indocyanine green (ICG) is a vital fluorescent agent.
  • ICG offers broad applications in surgical visualization, structure differentiation, and lesion localization.

Purpose of the Study:

  • To investigate novel applications of ICG in modern gynecological oncology.
  • To review ICG's role in ovarian and endometrial cancer surgery.

Main Methods:

  • Overview of ICG applications in gynecological oncology.
  • Analysis of ICG in ureteral visualization, lymphography, and bowel surgery.

Main Results:

  • ICG aids in compartmental approaches for ovarian and endometrial cancer.
  • ICG improves surgical safety by reducing complications and enhancing patient quality of life.
  • ICG is crucial for lymph node detection and localization of anastomotic leakage.

Conclusions:

  • ICG is a versatile tool in gynecological surgery, enhancing precision and patient outcomes.
  • Preclinical models suggest ICG's future therapeutic potential as a cytotoxic agent.
  • Further studies are needed to explore ICG in various surgical settings and as a curative agent.